Mark Carrier is researcher and the chair of the hemostasis and malignancies subcommittee of ISTH. During this interview he goes through what the subcommittee does, why their activities are important and how does it interlace with ICTHIC. He has two big phase 3 studies now recruiting, the AVERT study ad the PERI-OP, which he hopes they will bring favourable results. He believes in the importance of real-world data to be implemented with the results of the studies, so that said knowledge can be applied to the whole patient population.
None of the information published on the ICTHC magazine website, in particular, information related to the choice and use of drugs, replaces the advice of a doctor.
Accept to continue
By registering to the newsletter, the User’s email address will be added to the contact list of ICTHIC Magazine, in order to receive email messages concerning the content published in ICTHIC Magazine and related promotional content/activities. Your email address may also be added to this list as a result of signing up to this Website. Personal Data collected: email address, first name, last name, profession.
ICTHIC CONFERENCE Newsletter By registering to the newsletter, the User’s email address will be added to the contact list of ICTHIC, in order to receive newsletters concerning the conference, such as Save the date, information about the meeting venue, the publication of the program, registration fees and deadline, abstract submission deadline and oral communication/poster instructions, hotel booking availability and deadline, social program for accompanying persons, the publication of speakers slides, photo/videogallery of the last edition and information about future editions of the conference. Your email address may also be added to this list as a result of signing up to this Website.